Subcellular anti-atherosclerotic therapy

Anastasia V. Ryabova; Igor D. Romanishkin; Aleksey S. Skobeltsin; Arkadii S. Moskalev; Vladimir I. Makarov; Victor B. Loschenov; Nikita G. Nikiforov; Igor A. Sobenin; Alexander N. Orekhov

doi:10.20517/2574-1209.2019.10

Vessel Plus ›› 2019, Vol. 3 ›› Issue (1) :17 DOI: 10.20517/2574-1209.2019.10

Letter to Editor

Subcellular anti-atherosclerotic therapy

Author information +

History +

PDF

Cite this article

Download citation ▾

Anastasia V. Ryabova, Igor D. Romanishkin, Aleksey S. Skobeltsin, Arkadii S. Moskalev, Vladimir I. Makarov, Victor B. Loschenov, Nikita G. Nikiforov, Igor A. Sobenin, Alexander N. Orekhov. Subcellular anti-atherosclerotic therapy. Vessel Plus, 2019, 3(1): 17 DOI:10.20517/2574-1209.2019.10

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Cai Y,Huang W,Shao J.Organic dye based nanoparticles for cancer phototheranostics..Small2018;14:e1704247

[2]	Kang HC.Mitochondria-targeting theranostics..Biomater Res2018;22:34 PMCID:PMC6225566

[3]	Sazonova MA,Sinyov VV,Orekhova VA.New markers of atherosclerosis: a threshold level of heteroplasmy in mtDNA mutations..Vessel Plus2017;1:182-91

[4]	Orekhov AN.Introduction of the special issue “atherosclerosis and related diseases”..Vessel Plus2017;1:163-5

[5]	Nikiforov NG,Nedosugova LV,Kolmychkova KI.Proinflammatory monocyte polarization in type 2 diabetes mellitus and coronary heart disease..Vessel Plus2017;1:192-5